Arphio

Arphio is a specialized pharmaceutical company focused on providing global access to orphan drugs for patients with rare diseases. Founded as a joint venture involving the Helsinn Group, the company operates a unique commercialization platform that bridges the gap between orphan drug developers and underserved markets, particularly in Central and Eastern Europe, the Middle East, and North Africa. Arphio provides comprehensive services including regulatory affairs, market access, medical affairs, and distribution. By leveraging its extensive network and expertise in rare diseases, the company aims to ensure that life-changing treatments reach patients regardless of their geographic location.